MARKET

CAH

CAH

Cardinal Health
NYSE

Real-time Quotes | Nasdaq Last Sale

58.28
+0.01
+0.02%
Opening 12:07 06/16 EDT
OPEN
58.20
PREV CLOSE
58.27
HIGH
58.56
LOW
58.05
VOLUME
727.89K
TURNOVER
--
52 WEEK HIGH
62.96
52 WEEK LOW
44.65
MARKET CAP
16.91B
P/E (TTM)
14.90
1D
5D
1M
3M
1Y
5Y
Cardinal Health Inc. stock falls Tuesday, still outperforms market
marketwatch.com · 19h ago
Cardinal Health Inc. stock underperforms Monday when compared to competitors
marketwatch.com · 1d ago
At US$59.31, Is It Time To Put Cardinal Health, Inc. (NYSE:CAH) On Your Watch List?
Cardinal Health, Inc. ( NYSE:CAH ) saw a decent share price growth in the teens level on the NYSE over the last few...
Simply Wall St. · 4d ago
Cardinal Health's (CAH) Arm Receives FDA Nod for LYMPHOSEEK
Cardinal Health's (CAH) Nuclear & Precision Health Solutions receive FDA approval for LYMPHOSEEK injection.
Zacks · 5d ago
Cardinal Health Inc. stock rises Thursday, outperforms market
marketwatch.com · 5d ago
Cardinal Health announces FDA approval of LYMPHOSEEK for use in children
Grandbrothers/iStock Editorial via Getty Images Cardinal Health (CAH) announced that the FDA has approved LYMPHOSEEK (technetium Tc 99m tilmanocept) for pediatric use. LYMPHOSEEK, a radioactive diagnostic agent is the “first and
Seekingalpha · 6d ago
BRIEF-Cardinal Health Nuclear & Precision Health Solutions Receives U.S. Food And Drug Administration Approval For New Lymphoseek Pediatric Indication
reuters.com · 6d ago
Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication
/PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that (technetium Tc tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies (SLNB) – h...
PR Newswire - PRF · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CAH. Analyze the recent business situations of Cardinal Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CAH stock price target is 63.36 with a high estimate of 74.00 and a low estimate of 56.00.
EPS
Institutional Holdings
Institutions: 1.11K
Institutional Holdings: 262.31M
% Owned: 90.40%
Shares Outstanding: 290.15M
TypeInstitutionsShares
Increased
282
13.94M
New
98
2.01M
Decreased
276
15.49M
Sold Out
74
2.20M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
-0.21%
Food & Drug Retailing
-0.58%
Key Executives
Non-Executive Chairman/Independent Director
Gregory Kenny
Chief Executive Officer/Director
Michael Kaufmann
Chief Financial Officer
Jason Hollar
Corporate Executive
Victor Crawford
Corporate Executive
Stephen Mason
Chief Human Resource Officer
Ola Snow
Executive Vice President/Chief Information Officer
Brian Rice
Director
J. Michael Losh
Director
John Michael Losh
Chief Compliance Officer
Jessica Mayer
Independent Director
Carrie Cox
Independent Director
Bruce Downey
Independent Director
Sheri Edison
Independent Director
David Evans
Independent Director
Patricia Hemingway Hall
Independent Director
Akhil Johri
Independent Director
Nancy Killefer
Independent Director
John Losh
Independent Director
Dean Scarborough
Independent Director
John Weiland
Declaration Date
Dividend Per Share
Ex-Div Date
05/06/2021
Dividend USD 0.4908
06/30/2021
02/05/2021
Dividend USD 0.4859
03/31/2021
11/05/2020
Dividend USD 0.4859
12/31/2020
08/06/2020
Dividend USD 0.4859
09/30/2020
05/11/2020
Dividend USD 0.4859
06/30/2020
02/11/2020
Dividend USD 0.4811
03/31/2020
11/07/2019
Dividend USD 0.4811
12/31/2019
08/07/2019
Dividend USD 0.4811
09/30/2019
05/08/2019
Dividend USD 0.4811
06/28/2019
02/07/2019
Dividend USD 0.4763
03/29/2019
11/07/2018
Dividend USD 0.476
12/31/2018
08/08/2018
Dividend USD 0.476
09/28/2018
05/09/2018
Dividend USD 0.476
06/29/2018
02/07/2018
Dividend USD 0.462
03/29/2018
11/08/2017
Dividend USD 0.462
12/29/2017
08/10/2017
Dividend USD 0.462
09/29/2017
05/04/2017
Dividend USD 0.462
06/29/2017
02/03/2017
Dividend USD 0.449
03/30/2017
11/04/2016
Dividend USD 0.449
12/29/2016
08/08/2016
Dividend USD 0.449
09/29/2016
  • All
  • Financials
  • Insiders
More
About CAH
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Webull offers kinds of Cardinal Health Inc stock information, including NYSE:CAH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CAH stock methods without spending real money on the virtual paper trading platform.